Albumin-based therapeutic nanoprobes, with multimodal imaging and photothermal therapy capabilities, as well as a “photothermal ablation-assisted surgery” strategy, hold promise for clinical cancer therapy in the future [62]. This evidence concerns the gene ALB and cancer.